Complications of retained pacemaker hardware in heart transplant recipients: case series and review of the literature.


Journal

Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 11 12 2019
accepted: 06 03 2020
pubmed: 5 4 2020
medline: 5 3 2021
entrez: 5 4 2020
Statut: ppublish

Résumé

Heart transplantation (HT) in patients with prior cardiovascular implantable electronic devices (CIEDs) is becoming more common, in parallel with the increased use of CIEDs for patients with advanced heart failure. Complete removal of CIED components during HT is not always feasible, and it is thus surprising that the literature addressing the implications of retained CIED components is limited. Indeed, there are neither guidelines nor consensus regarding the need for removal of these CIED fragments. This issue is nonetheless becoming important in light of the increase in the percentage of HT candidates having CIEDs, on the one hand, and newer therapeutic immunosuppressive protocols with higher bacterial infection potential, on the other. Thus, with the aim to study the implications of retained CIED fragments as a step towards establishing a therapeutic approach for the unique population of HT recipients with CIED remnants, we present here a case series of HT patients with retained CIED fragments who developed complications of infections together with a review of the available literature.

Identifiants

pubmed: 32246271
doi: 10.1007/s15010-020-01410-x
pii: 10.1007/s15010-020-01410-x
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

635-640

Auteurs

Alexander Fardman (A)

Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Hashomer, 52621, Ramat Gan, Israel. alexfardman@gmail.com.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel. alexfardman@gmail.com.

Eilon Ram (E)

Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Hashomer, 52621, Ramat Gan, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Jacob Lavee (J)

Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Hashomer, 52621, Ramat Gan, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Anat Wieder (A)

Infectious Disease Unit, Chaim Sheba Medical Center, Ramat Gan, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Roy Beinart (R)

Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Hashomer, 52621, Ramat Gan, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Eyal Nof (E)

Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Hashomer, 52621, Ramat Gan, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Yael Peled (Y)

Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Hashomer, 52621, Ramat Gan, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH